Dr Mitchell argued "recurrent treatment with blood products is hazardous... The best approach seems to us to be a treatment policy" designed to reduce all the risks associated with blood products and is tailored to the needs of individual patients.
Chronology Information
Date:
Chapter/issue
Haemophilia Centres: Policies and Practice
Key Person(s)
Dr Vivian Mitchell